lobbying_filings_raw: 46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec Q3 401109327 PARATEK PHARMACEUTICALS 64825 PARATEK PHARMACEUTICALS 2025 third_quarter 2025-09-29T15:58:25-04:00 20000.0 0 0 0 {"url": "https://lda.gov/api/v1/filings/46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec/", "filing_uuid": "46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2025, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.gov/filings/public/filing/46cf3dfb-11f1-49a7-a39b-4bbb8a92ffec/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "20000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Benjamin A Novak", "dt_posted": "2025-09-29T15:58:25-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1000 First Avenue", "registrant_address_2": "Suite 200", "registrant_different_address": false, "registrant_city": "King of Prussia", "registrant_state": "PA", "registrant_zip": "19406", "registrant": {"id": 401109327, "url": "https://lda.gov/api/v1/registrants/401109327/", "house_registrant_id": 66886, "name": "PARATEK PHARMACEUTICALS", "description": null, "address_1": "1000 First Avenue", "address_2": "Suite 200", "address_3": null, "address_4": null, "city": "King of Prussia", "state": "PA", "state_display": "Pennsylvania", "zip": "19406", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "BENJAMIN NOVAK", "contact_telephone": "+1 657-600-1827", "dt_updated": "2025-12-22T09:43:38.778549-05:00"}, "client": {"id": 64825, "url": "https://lda.gov/api/v1/clients/64825/", "client_id": 64825, "name": "PARATEK PHARMACEUTICALS", "general_description": "Pharmaceuticals - Antibiotics & Biodefense", "client_government_entity": null, "client_self_select": true, "state": "PA", "state_display": "Pennsylvania", "country": "US", "country_display": "United States of America", "ppb_state": "PA", "ppb_state_display": "Pennsylvania", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2025-03-01"}, "lobbying_activities": [{"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding", "foreign_entity_issues": "Private Equity firm investment in the company.", "lobbyists": [{"lobbyist": {"id": 148979, "prefix": null, "prefix_display": null, "first_name": "BENJAMIN", "nickname": null, "middle_name": null, "last_name": "NOVAK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} PA US 66886 PA PA US US Pharmaceuticals - Antibiotics & Biodefense   0 2104480   normalized_name 0.7

Links from other tables